TABLE 4.
ATN
2-Drug | 3-Drug | Total | 2 vs. 3 | Subgroup | |
---|---|---|---|---|---|
Overall | 41% | 34% | 38% | NS | |
1st Transplant | 37% | 31% | 34% | NS | NS |
Retransplantation | 52% | 41% | 46% | NS | |
Cadaveric | 48% | 37% | 42% | NS | P < .001 |
Living-donor | 11% | 0 | 8% | NS | |
PRA <40% | 40% | 29% | 35% | NS | NS |
PRA >40% | 47% | 55% | 51% | NS | |
Black | 54% | 60% | 57% | NS | P < .03 |
Nonblack | 39% | 30% | 35% | NS | |
Donors >60 years | 54% | 50% | 52% | NS | NS |
Donors <60 years | 39% | 33% | 36% | NS | |
Recipients <60 years | 42% | 31% | 37% | NS | NS |
Recipients >60 years | 36% | 46% | 42% | NS | |
CIT | |||||
<12 hr | 11% | 0 | 8% | NS | P < .001 |
>24 hr | 0 | 29% | 16% | NS | |
>24 hr | 46% | 30% | 39% | NS | |
>36 hr | 79% | 53% | 63% | NS |